about
Developing novel anthelmintics from plant cysteine proteinases.Molecular determinants archetypical to the phylum NematodaStudies Towards Paraherquamides E & F and Related C-labeled Putative Biosynthetic Intermediates: Stereocontrolled Synthesis of the α-Alkyl-β-Methylproline Ring System.Using a health-rating system to evaluate the usefulness of Caenorhabditis elegans as a model for anthelmintic studyEchinococcus multilocularis alkaline phosphatase as a marker for metacestode damage induced by in vitro drug treatment with albendazole sulfoxide and albendazole sulfone.Drug-based helminth control in Western Pacific countries: a general perspective.Progress and new technologies for developing vaccines against gastrointestinal nematode parasites of sheep.Effect of combinations of marketed human anthelmintic drugs against Trichuris muris in vitro and in vivoStudies on Paraherquamide Biosynthesis: Synthesis of Deuterium-Labeled 7-Hydroxy-Pre-Paraherquamide, a Putative Precursor of Paraherquamides A, E & FNitazoxanide: nematicidal mode of action and drug combination studies.Control of nematode parasites with agents acting on neuro-musculature systems: lessons for neuropeptide ligand discovery.The 125-year life cycle of parasite control.Evaluation of anthelmintic activity of biologically synthesized silver nanoparticles against the gastrointestinal nematode, Haemonchus contortus.Anthelmintic activity of Cymbopogon citratus against Haemonchus contortus.In vitro effects of Coriandrum sativum, Tagetes minuta, Alpinia zerumbet and Lantana camara essential oils on Haemonchus contortus.Anthelmintic activity of botanical extracts against sheep gastrointestinal nematodes, Haemonchus contortus.Anti-Onchocerca and Anti-Caenorhabditis Activity of a Hydro-Alcoholic Extract from the Fruits of Acacia nilotica and Some Proanthocyanidin Derivatives.Phytochemical analysis and in vitro anthelmintic activity of Lophira lanceolata (Ochnaceae) on the bovine parasite Onchocerca ochengi and on drug resistant strains of the free-living nematode Caenorhabditis elegansIn vivo effect of selected medicinal plants against gastrointestinal nematodes of sheep.The use of DNA markers to map anthelmintic resistance loci in an intraspecific cross of Haemonchus contortus.Fumagillin, a new P-glycoprotein-interfering agent able to modulate moxidectin efflux in rat hepatocytes.Pharmacokinetics of a new long acting endectocide formulation containing 2.25% ivermectin and 1.25% abamectin in cattle.
P2860
Q24658119-330FA9E1-5625-4D07-8F45-140C88A11DE4Q33419513-83EBE10F-38F2-4B48-9288-F6EA795800B3Q33750464-A14C3178-68BF-4337-AB01-79629B8E65E9Q33817389-82FF42E0-F7A1-4D46-8B66-83B2EE0BD225Q33982701-2826B296-8750-45C3-96A7-F5E86FD224ACQ34434840-26472C26-C873-4A6F-8F50-E8BFCE823243Q35217060-8C812581-94C0-4462-83BF-512918FB4D06Q36499326-5A502959-CB47-47E0-9182-885629841EBBQ37234744-E99D9FE0-F621-447E-916E-EF5E32E623CDQ37678601-053E0D63-28FF-49C8-A4A1-49DDEE99DD51Q37824390-B6DCF67B-B192-46DE-819F-61C2C0685798Q38124800-74A346C4-5B8D-4C5D-91D2-D29225A58CE3Q38408648-9D778095-7525-4ABB-9AD4-2FE7F7E51693Q38411865-3FC02E4A-A69F-46B7-A541-9194007F35A9Q38418668-01FBBD1D-E080-4B71-8520-D4DA6E7C390CQ38429436-C9AB176B-2057-4E9D-9384-5B202A45A2E8Q38704367-88EE3151-2EF1-4597-A2EC-B06FA24861CBQ39116688-1BFD9162-3BCB-476D-BD9D-9DFE74789342Q43680963-99ECCD1A-70B0-4092-92B7-25EE712B0433Q46513983-53F6157F-348D-4967-AAE1-D64B5B937509Q52673902-4F504E9D-F8C0-4D79-957B-982AFCA1DF06Q52675822-1324298F-C85D-4AB4-AA1A-4379ECDBB03A
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Frontiers in anthelmintic pharmacology.
@ast
Frontiers in anthelmintic pharmacology.
@en
type
label
Frontiers in anthelmintic pharmacology.
@ast
Frontiers in anthelmintic pharmacology.
@en
prefLabel
Frontiers in anthelmintic pharmacology.
@ast
Frontiers in anthelmintic pharmacology.
@en
P2093
P1476
Frontiers in anthelmintic pharmacology.
@en
P2093
D P Thompson
N C Sangster
P304
P356
10.1016/S0304-4017(99)00042-4
P577
1999-08-01T00:00:00Z